TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
In a MedPage Today video published Oct. 19, 2026, Michael Osterholm argued that credible vaccine-safety research requires transparent methods, study plans set before analysis, reproducible results and expert review. The interview presents his views on how studies should be conducted; it does not report findings from a new safety study.
Michael Osterholm, executive director of the Vaccine Integrity Project, said credible vaccine-safety studies need transparent methods, predetermined study designs and reproducible analyses, in a MedPage Today interview published Oct. 19, 2026. His comments address how researchers and reviewers can assess proposed studies amid public concern about vaccine safety and trust; the interview does not announce new research findings.
Osterholm argued that researchers should explain why a study is being conducted and what information gap it is intended to address. He said study decisions—including how to define vaccinated and unvaccinated groups, identify outcomes and assess possible adverse reactions—should be made before researchers examine results. Setting those choices in advance, he said, can reduce the risk of selecting analyses or figures after the fact to support a preferred conclusion.
He also emphasized that other researchers and members of the public should be able to inspect the data and repeat the analysis. Osterholm said his organization provides a tool through which users can run the same analysis and document differences. The interview does not provide enough detail to independently assess the tool, its underlying data or how broadly it is used.
Osterholm said findings require expert scrutiny before they are interpreted. He cautioned that repeated statistical tests can produce an apparent association by chance, and that an association alone does not establish cause and effect. A result that raises a signal, in his view, should prompt consideration of whether further study is warranted—not an automatic conclusion about vaccine safety or effectiveness.
Methods Shape Safety Findings
Vaccine-safety research can affect public decisions and confidence, so readers need a way to judge more than a study’s headline result. Predefined methods, accessible data and independent review make it easier to see how researchers reached a conclusion, whether key definitions were consistent and whether other analysts obtain similar results.
Those safeguards do not guarantee that a study is correct, nor do they settle disagreements about a particular vaccine. They help make the evidence open to scrutiny. Osterholm’s concern is that a result could be presented publicly as proof of harm or lack of effectiveness before its methods and interpretation have been adequately examined. That concern is his assessment, not a finding established by the interview.
vaccine safety research analysis tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
The Interview’s Research Focus
The report appeared in MedPage Today’s “Off the ‘Page” video series, which features perspectives on medical issues. It describes Osterholm’s comments as part of a recent viewpoint about standards for vaccine-safety research. The supplied report does not identify a specific new study, dataset or vaccine under investigation.
Osterholm said he believes the proposed studies he was discussing have not demonstrated benefits beyond the rigorous safety monitoring already in place for current vaccines. That is his assessment, and the interview material does not include an independent review of those proposals or evidence comparing them with existing monitoring. The distinction matters: the report is about research standards and public oversight, not a new evaluation of vaccine risk.
“The most important word that one can think about in talking about these kinds of studies is “transparency.””
— Michael Osterholm, executive director of the Vaccine Integrity Project
reproducible data analysis software
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence Behind the Proposals
The interview does not name the proposed studies Osterholm criticized, specify their designs or provide data that would allow readers to judge his assessment of them. It also does not present a new analysis of vaccine safety or compare particular monitoring systems.
Details about the data and replication tool he mentioned are limited in the supplied report. The interview likewise does not establish how independent review would be organized for each study, what findings would trigger additional research or whether other experts agree with Osterholm’s concerns. Those questions remain open based on the material available.
independent review tools for vaccine studies
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Scrutiny as Studies Proceed
Osterholm called for ongoing scrutiny while proposed studies are being designed and conducted, rather than waiting until a result is used in a public claim about vaccine safety or effectiveness. Under his approach, researchers would set definitions and analysis plans in advance, make their data and methods available for replication, and have qualified experts assess what the results do—and do not—show.
The report gives no schedule for specific studies, review decisions or further findings. The next meaningful development would be publication of study protocols, data and results that allow independent assessment. Until then, the interview provides a set of standards advocated by Osterholm, not a verdict on the safety of a particular vaccine or the validity of a particular study.
public data inspection software for medical research
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Did the report announce a new vaccine-safety finding?
No. It reports Osterholm’s views on research standards in a MedPage Today interview, not results from a new safety study.
What does Osterholm say makes a study credible?
He points to transparent methods, decisions made before researchers analyze results, reproducible analyses and expert review.
Why should study plans be set before researchers examine data?
Osterholm says advance decisions about groups, outcomes and analysis can help limit after-the-fact choices that might favor a particular conclusion. The interview presents this as his argument about sound study design.
Does finding an association prove a vaccine caused an outcome?
No. Osterholm cautioned that an association does not by itself establish cause and effect, and that repeated analyses can produce chance findings. A signal needs further evaluation.
What is not known from the interview?
The report does not identify the specific proposed studies, provide their protocols or results, or independently evaluate Osterholm’s claims about existing vaccine-safety monitoring.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
